Literature DB >> 2124959

Cytokine regulation of HLA on thyroid epithelial cells.

K Migita1, K Eguchi, T Otsubo, A Kawakami, H Nakao, Y Ueki, C Shimomura, A Kurata, T Fukuda, M Matsunaga.   

Abstract

The regulation of class I and class II HLA expression in human thyroid follicular cells was studied in vitro. Tumour necrosis factor-alpha (TNF-alpha) enhanced the expression of class I antigen on thyrocytes, but these cytokines had little effect on the expression of class II antigen. Interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6) did not affect class I and class II antigen expression. The combination of interferon-gamma (IFN-gamma) with TNF-alpha or IL-1 beta enhanced the induction of class I and class II antigens, compared with the effect of IFN-gamma alone. Neither class I nor class II expression was induced by IL-6 alone or in combination with IFN-gamma. These findings suggest that TNF-alpha and IL-1 beta may have an important role in inappropriate expression of HLA antigens on thyrocytes in thyroid gland.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124959      PMCID: PMC1535486          DOI: 10.1111/j.1365-2249.1990.tb05488.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.

Authors:  M Matsunaga; K Eguchi; T Fukuda; A Kurata; H Tezuka; C Shimomura; T Otsubo; N Ishikawa; K Ito; S Nagataki
Journal:  J Clin Endocrinol Metab       Date:  1986-04       Impact factor: 5.958

2.  Cocultures of human thyroid monolayer cells and autologous T cells: impact of HLA class II antigen expression.

Authors:  T F Davies
Journal:  J Clin Endocrinol Metab       Date:  1985-09       Impact factor: 5.958

3.  Release of interleukin-1 from human synovial tissue in vitro.

Authors:  D D Wood; E J Ihrie; D Hamerman
Journal:  Arthritis Rheum       Date:  1985-08

4.  Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.

Authors:  M Tsujimoto; Y K Yip; J Vilcek
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

5.  Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells.

Authors:  M Londei; G F Bottazzo; M Feldmann
Journal:  Science       Date:  1985-04-05       Impact factor: 47.728

6.  The in vitro regulation of human thyrocyte HLA-DR antigen expression.

Authors:  A P Weetman; D J Volkman; K D Burman; T L Gerrard; A S Fauci
Journal:  J Clin Endocrinol Metab       Date:  1985-11       Impact factor: 5.958

7.  Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro.

Authors:  T Collins; L A Lapierre; W Fiers; J L Strominger; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

8.  Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1 alpha and interleukin-6.

Authors:  B Grubeck-Loebenstein; G Buchan; D Chantry; H Kassal; M Londei; K Pirich; K Barrett; M Turner; W Waldhausl; M Feldmann
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

9.  Recombinant interferon-gamma increases HLA-DR synthesis and expression.

Authors:  T Y Basham; T C Merigan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

10.  Interferon-gamma induces HLA-DR expression by thyroid epithelium.

Authors:  I Todd; R Pujol-Borrell; L J Hammond; G F Bottazzo; M Feldmann
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

View more
  2 in total

1.  Thyrotropin modifies activation of nuclear factor kappaB by tumour necrosis factor alpha in rat thyroid cell line.

Authors:  T Kikumori; F Kambe; T Nagaya; H Funahashi; H Seo
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

2.  Nonimmune thyroid destruction results from transgenic overexpression of an allogeneic major histocompatibility complex class I protein.

Authors:  A G Frauman; P Chu; L C Harrison
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.